open access
Retained products of conception — a retrospective analysis of 200 cases of surgical procedures for the diagnosis of residua postpartum
- 3rd Faculty of Medicine, Institute for the Care of Mother and Child, Charles University, Prague, Czech Republic
open access
Abstract
Objectives: Postpartum retained products of conception are a relatively rare diagnosis occurring in approximately 1% of cases after spontaneous deliveries and abortions. The most common clinical signs are bleeding and abdominal pain. The diagnosis is based on clinical signs and ultrasound examination.
Material and methods: Retrospective analysis of 200 surgical procedures for the diagnosis of residua postpartum obtained in 64 months. We correlated the method and accuracy of diagnosis with definitive histological findings.
Results: During 64 months, we performed 23 412 deliveries. The frequency of procedures for diagnosis of retained products of conception (RPOC) was 0.85%. Most (73.5%) of the D&C were performed within six weeks of delivery. Histologically, the correct diagnosis was confirmed in 62% (chorion + amniotic envelope). There was interestingly lower concordance of histologically confirmed RPOC in post-CS patients (only 42%). In women after spontaneous delivery of the placenta, the diagnosis of RPOC was confirmed by histological correlate in 63%, and the highest concordance occurred in women after manual removal of the placenta in 75%.
Conclusions: Concordance with histological findings of chorion or amnion was seen in 62% of cases; this means that the
incidence rate in our study was around 0.53%. The lowest concordance is after CS deliveries, 42%. D&C for RPOC should be performed after adequate clinical evaluation and in the knowledge of 38% false positivity. There is certainly more space for a conservative approach under appropriate clinical conditions, especially in patients after CS.
Abstract
Objectives: Postpartum retained products of conception are a relatively rare diagnosis occurring in approximately 1% of cases after spontaneous deliveries and abortions. The most common clinical signs are bleeding and abdominal pain. The diagnosis is based on clinical signs and ultrasound examination.
Material and methods: Retrospective analysis of 200 surgical procedures for the diagnosis of residua postpartum obtained in 64 months. We correlated the method and accuracy of diagnosis with definitive histological findings.
Results: During 64 months, we performed 23 412 deliveries. The frequency of procedures for diagnosis of retained products of conception (RPOC) was 0.85%. Most (73.5%) of the D&C were performed within six weeks of delivery. Histologically, the correct diagnosis was confirmed in 62% (chorion + amniotic envelope). There was interestingly lower concordance of histologically confirmed RPOC in post-CS patients (only 42%). In women after spontaneous delivery of the placenta, the diagnosis of RPOC was confirmed by histological correlate in 63%, and the highest concordance occurred in women after manual removal of the placenta in 75%.
Conclusions: Concordance with histological findings of chorion or amnion was seen in 62% of cases; this means that the
incidence rate in our study was around 0.53%. The lowest concordance is after CS deliveries, 42%. D&C for RPOC should be performed after adequate clinical evaluation and in the knowledge of 38% false positivity. There is certainly more space for a conservative approach under appropriate clinical conditions, especially in patients after CS.
Keywords
retained products of conception; D& C; hysteroscopic resection; manually removed placenta
Title
Retained products of conception — a retrospective analysis of 200 cases of surgical procedures for the diagnosis of residua postpartum
Journal
Issue
Article type
Research paper
Pages
967-971
Published online
2023-07-11
Page views
550
Article views/downloads
622
DOI
Pubmed
Bibliographic record
Ginekol Pol 2023;94(12):967-971.
Keywords
retained products of conception
D&C
hysteroscopic resection
manually removed placenta
Authors
Petr Velebil
Lucie Hajkova Hympanova
Hynek Herman
Michal Emingr
Petr Krepelka
Jiri Hanacek
- Wolman I, Altman E, Faith G, et al. Combined clinical and ultrasonographic work-up for the diagnosis of retained products of conception. Fertil Steril. 2009; 92(3): 1162–1164.
- Abbasi S, Jamal A, Eslamian L, et al. Role of clinical and ultrasound findings in the diagnosis of retained products of conception. Ultrasound Obstet Gynecol. 2008; 32(5): 704–707.
- Carlan SJ, Scott WT, Pollack R, et al. Appearance of the uterus by ultrasound immediately after placental delivery with pathologic correlation. J Clin Ultrasound. 1997; 25(6): 301–308, doi: 10.1002/(sici)1097-0096(199707)25:6<301::aid-jcu3>3.0.co;2-g.
- de Vries JI, van der Linden RM, van der Linden HC. Predictive value of sonographic examination to visualize retained placenta directly after birth at 16 to 28 weeks. J Ultrasound Med. 2000; 19(1): 7–12; quiz 13.
- Sadan O, Golan A, Girtler O, et al. Role of sonography in the diagnosis of retained products of conception. J Ultrasound Med. 2004; 23(3): 371–374.
- Pather S, Ford M, Reid R, et al. Postpartum curettage: an audit of 200 cases. Aust N Z J Obstet Gynaecol. 2005; 45(5): 368–371.
- Wolman I, Gordon D, Yaron Y, et al. Transvaginal sonohysterography for the evaluation and treatment of retained products of conception. Gynecol Obstet Invest. 2000; 50(2): 73–76.
- Rottenstreich M, Rotem R, Bergman M, et al. Recurrence of retained placenta in multiple consecutive deliveries. J Matern Fetal Neonatal Med. 2021; 34(21): 3574–3579.
- Granfors M, Sandström A, Stephansson O, et al. Placental location and risk of retained placenta in women with a previous cesarean section: A population-based cohort study. Acta Obstet Gynecol Scand. 2020; 99(12): 1666–1673.
- Perlman N, Carusi D. <p>Retained placenta after vaginal delivery: risk factors and management</p>. International Journal of Women's Health. 2019; Volume 11: 527–534.
- Jauniaux E, Chantraine F, Silver RM, et al. FIGO Placenta Accreta Diagnosis and Management Expert Consensus Panel. FIGO consensus guidelines on placenta accreta spectrum disorders: Epidemiology. Int J Gynaecol Obstet. 2018; 140(3): 265–273.
- Barel O, Krakov A, Pansky M, et al. Intrauterine adhesions after hysteroscopic treatment for retained products of conception: what are the risk factors? Fertil Steril. 2015; 103(3): 775–779.